I’d never suggest the LTR management set out to deliberately mislead shareholders - accidentally perhaps?
The nameplate production according to LTRs own website is 500ktpa of Spodumene Concentrate.
You are referring to 3mtpa and the expansion to 4mtpa which is not “nameplate” production - it is simply the amount of Ore being processed.
As per the attached from LTRs own website - the expansion nameplate (700ktpa Spodumene Concentrate) was supposed to be achieved by “year 6”. This has now been deferred/scrapped.
So - my original question remains - when will LTR achieve nameplate production of 500ktpa of 6% Spodumene Concentrate given that the expanded plan was supposed to be achieved year 6?
I think you may find that IF the funding is approved it will be tied to very specific usage cases which themselves will be linked to key project milestones/deliverables.
Cheers
DYOR IMO
- Forums
- ASX - By Stock
- LTR
- ASX Today
ASX Today, page-39740
-
-
- There are more pages in this discussion • 2,095 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTR (ASX) to my watchlist
|
|||||
Last
95.5¢ |
Change
-0.010(1.04%) |
Mkt cap ! $2.340B |
Open | High | Low | Value | Volume |
96.0¢ | 96.5¢ | 94.5¢ | $1.809M | 1.894M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 116112 | 95.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.0¢ | 162899 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 268611 | 0.950 |
13 | 627092 | 0.945 |
23 | 496513 | 0.940 |
7 | 393355 | 0.935 |
24 | 621424 | 0.930 |
Price($) | Vol. | No. |
---|---|---|
0.955 | 3 | 1 |
0.960 | 203827 | 19 |
0.965 | 147702 | 11 |
0.970 | 142817 | 7 |
0.975 | 64039 | 8 |
Last trade - 10.28am 25/07/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online